No federal rescheduling vote reaches the House floor in 2026.

For a law to pass in the US, it first has to come up for a vote on the floor of the House of Representatives. No bill to change the legal status of psilocybin or MDMA is even in line to get that vote in 2026. Politicians right now prefer funding research rather than taking the politically risky step of loosening drug laws, especially with elections on the horizon.

No scheduling bill appears in today's active docket. Political appetite favors funding pathways over descheduling controversy in an election-adjacent year.